Kraft Heinz
KHC
$22.42
-0.22%
The Kraft Heinz Company is a leading global food and beverage manufacturer, operating in the Consumer Defensive sector's Packaged Foods industry with a portfolio of iconic brands including Kraft, Heinz, Oscar Mayer, Velveeta, and Philadelphia. The company is a dominant player in North America, deriving around 85% of sales from retail channels, while also maintaining a growing international footprint that accounts for approximately 25% of its revenue. The current investor narrative is shaped by a significant strategic reversal under the active engagement of its major shareholder, Berkshire Hathaway, signaling a potential turnaround story, while the stock is also being highlighted as a potential value and high-yield opportunity as it trades near 52-week lows amidst sector headwinds.…
KHC
Kraft Heinz
$22.42
Related headlines
Investment Opinion: Should I buy KHC Today?
Rating & Thesis: KHC is a speculative HOLD, suitable only for high-risk-tolerance, income-oriented investors willing to bet on a successful, Berkshire-backed turnaround from deeply depressed levels. The analyst consensus is neutral-to-bearish, with recent downgrades to 'Underweight', and while a specific price target is unavailable, the forward P/E of 10.27x suggests the market expects modest earnings recovery.
Supporting Evidence: The primary valuation metric, a PS ratio of 1.15x, is at a multi-year low and represents a deep-value proposition. The forward P/E of 10.27x is reasonable if the company delivers on the estimated $2.20 EPS. Underlying operations are cash-generative, with $3.66B in TTM FCF supporting the high 6.63% yield. However, these positives are counterbalanced by a -3.38% YoY revenue decline and severe -25.98% 1-year price underperformance versus the market.
Risks & Conditions: The two biggest risks are persistent revenue decline invalidating the turnaround thesis and a dividend cut if cash flow deteriorates. This HOLD would upgrade to a BUY if quarterly revenue growth turns positive or stabilizes, or if the forward P/E compresses below 9x on sustained earnings delivery. It would downgrade to a SELL if the price breaks decisively below the $21.035 support on worsening fundamentals. The stock is fairly valued to slightly undervalued relative to its own distressed history but remains overvalued relative to any growth expectations, as the market is pricing in stagnation.
Sign up to view all
KHC 12-Month Price Forecast
KHC presents a classic conundrum of value versus growth. The quantitative case for value is strong (low PS, high yield, low beta), but the qualitative growth narrative is weak (revenue decline, analyst downgrades). The neutral stance reflects this balance, with a base-case probability of 55% for continued sideways movement. The stance would upgrade to bullish on evidence of revenue stabilization or a successful strategic pivot communicated in upcoming earnings. It would downgrade to bearish on a breakdown below $21.035 or a warning on the dividend's sustainability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Kraft Heinz's 12-month outlook, with a consensus price target around $29.15 and implied upside of +30.0% versus the current price.
Average Target
$29.15
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$18 - $29
Analyst target range
Analyst coverage is limited, with only 5 analysts providing estimates, and the institutional ratings data shows a consensus leaning bearish to neutral, with recent actions including 'Underweight' from JP Morgan and Morgan Stanley, and 'Hold' or 'Equal Weight' from others like Deutsche Bank and Wells Fargo. The average analyst revenue estimate for the upcoming period is $24.96 billion, with a low of $24.59 billion and a high of $25.62 billion, while the average EPS estimate is $2.20, ranging from $2.15 to $2.27; however, a specific consensus price target is not provided in the data, implying insufficient data to calculate a clear implied upside or downside from the current price. The wide range between the low and high EPS estimates signals moderate uncertainty about the pace of the earnings recovery, with the high target likely assuming successful execution of the strategic reversal and margin improvement, while the low target may factor in persistent top-line weakness and competitive pressures. The pattern of recent analyst actions shows stability in neutral ratings but notable downgrades to Underweight from major firms like JP Morgan and Morgan Stanley in early 2026, reflecting ongoing caution despite the stock's depressed valuation.
Bulls vs Bears: KHC Investment Factors
The evidence currently tilts bearish, as the fundamental headwinds of revenue decline, analyst skepticism, and severe market underperformance outweigh the potential value and yield attractions. The most critical tension in the KHC investment debate is whether the company's strong cash generation and deep-value valuation can offset its inability to achieve sustainable top-line growth. The resolution hinges on the success of the Berkshire-backed strategic reversal in reigniting brand relevance and stabilizing revenues; without this, the stock risks remaining a 'value trap' despite its high dividend.
Bullish
- Deep Value at 52-Week Low: Trading at $21.94, KHC is at just 21% of its 52-week range ($21.035 to $29.74), indicating extreme pessimism is priced in. The trailing PS ratio of 1.15x is near the bottom of its multi-year historical range, suggesting a potential margin of safety if the business stabilizes.
- Strong Cash Flow & High Yield: The company generated $3.66 billion in TTM free cash flow and $1.38 billion in operating cash flow in Q4 2025, providing ample liquidity. This funds a substantial 6.63% dividend yield, which is attractive for income-focused investors in a low-growth environment.
- Return to Underlying Profitability: Despite a TTM net loss due to a massive Q2 2025 impairment charge, Q4 2025 showed a return to core profitability with net income of $651 million and a gross margin of 32.61%. The forward P/E of 10.27x, based on estimated EPS of $2.20, reflects expectations for an earnings recovery.
- Active Strategic Reversal: Major shareholder Berkshire Hathaway, under new CEO Greg Abel, is actively engaged in a strategic reversal at KHC. This high-level oversight signals a commitment to turning around the iconic but stagnant brand portfolio, providing a catalyst not present in passive holdings.
Bearish
- Persistent Revenue Decline: Q4 2025 revenue of $6.35 billion declined -3.38% YoY, continuing a trend of stagnant to negative top-line growth. The lack of consistent revenue momentum challenges the turnaround narrative for this mature consumer staples giant.
- Analyst Downgrades & Caution: Recent analyst actions include downgrades to 'Underweight' from JP Morgan and Morgan Stanley in early 2026, reflecting ongoing fundamental concerns. The limited coverage (5 analysts) and lack of a clear consensus price target indicate low conviction and visibility on the recovery path.
- Severe Underperformance vs. Market: KHC has dramatically underperformed, with a 1-year price change of -25.98% versus the SPY's gain of +30.59%. The stock's relative strength scores are deeply negative (-56.57 over 1 year), indicating sustained selling pressure and a lack of positive momentum.
- Profitability Clouded by Impairment: The trailing twelve-month net margin is -23.44% with EPS of -$0.20, heavily impacted by a $7.82 billion impairment charge in Q2 2025. While non-cash, this charge reflects past overpayments for assets and writedowns on brand value, raising questions about historical capital allocation.
KHC Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -25.98% as of the latest data. Currently trading at $21.94, the price sits at just 21% of its 52-week range ($21.035 to $29.74), positioning it near its absolute lows, which suggests deep value territory but also reflects significant fundamental and technical weakness. The short-term momentum shows a slight divergence, with a 1-month gain of 2.0% and a 3-month decline of -5.43%, indicating a potential for a minor bounce or consolidation after the steep longer-term decline, though the 6-month loss of -13.11% confirms the overarching bearish pressure remains intact. Key technical support is clearly defined at the 52-week low of $21.035, with a breakdown below this level signaling a potential acceleration of the downtrend, while resistance is established at the 52-week high of $29.74. The stock's beta of 0.051 indicates it has been dramatically less volatile than the broader market (SPY), which has gained 30.59% over the past year, highlighting KHC's severe underperformance and defensive, low-correlation characteristics that may appeal to specific risk-off portfolios.
Beta
0.05
0.05x market volatility
Max Drawdown
-31.2%
Largest decline past year
52-Week Range
$21-$29
Price range past year
Annual Return
-22.3%
Cumulative gain past year
| Period | KHC Return | S&P 500 |
|---|---|---|
| 1m | +0.4% | +12.6% |
| 3m | -3.1% | +2.5% |
| 6m | -9.3% | +4.3% |
| 1y | -22.3% | +28.4% |
| ytd | -8.1% | +4.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KHC Fundamental Analysis
Revenue growth is stagnant to slightly negative, with the most recent Q4 2025 revenue of $6.35 billion representing a year-over-year decline of -3.38%. The multi-quarter trend shows volatility, with Q2 2025 revenue of $6.35 billion followed by a dip in Q3 to $6.24 billion before the Q4 figure, indicating a lack of consistent top-line momentum, which challenges the growth narrative for this mature consumer staples giant. The company is profitable on an operating basis but has reported a trailing twelve-month net loss, as indicated by a negative net margin of -23.44% and negative EPS of -$0.20, largely driven by a massive $7.82 billion impairment charge in Q2 2025; however, the most recent quarter (Q4 2025) showed a return to profitability with net income of $651 million and a gross margin of 32.61%, suggesting underlying operations remain cash-generative despite the one-time hit. The balance sheet is relatively healthy with a moderate debt-to-equity ratio of 0.51 and a current ratio of 1.15, while the company generates substantial cash flow, evidenced by a trailing twelve-month free cash flow of $3.66 billion and an operating cash flow of $1.38 billion in Q4 2025, providing ample liquidity to fund its 6.63% dividend yield and navigate its strategic turnaround.
Quarterly Revenue
$6.4B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.32%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KHC Overvalued?
Given the negative trailing net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 1.15, while the forward-looking valuation can be inferred from the forward PE of 10.27, which is applicable as analysts expect a return to profitability with estimated EPS of $2.20; the significant gap between the negative trailing PE and positive forward PE underscores the market's expectation of a sharp earnings recovery post the Q2 2025 impairment. Compared to typical packaged food peers, a PS ratio of 1.15x is generally at a discount, suggesting the market is pricing in limited growth or margin challenges, which is consistent with the company's recent revenue decline and profitability issues. Historically, the stock's own PS ratio has fluctuated significantly, from a high above 7.0x in early 2022 to the current 1.15x; trading near the very bottom of its multi-year historical range indicates the market has priced in substantial pessimism, potentially offering a deep-value opportunity if the company's strategic initiatives successfully stabilize the business.
PE
-4.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -461x~96x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-13.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is earnings volatility, as evidenced by the swing from a $7.82 billion Q2 2025 impairment loss to a $651 million Q4 profit, creating uncertainty for investors. While the balance sheet is moderate (Debt/Equity 0.51), the company faces margin pressure with a gross margin of 33.3% and must continue generating substantial cash flow to support its high 6.63% dividend payout. Revenue concentration in mature North American retail (approx. 85% of sales) exposes KHC to stagnation in its core market, with recent quarterly revenue showing a -3.38% YoY decline.
Market & Competitive Risks: KHC trades at a significant valuation discount (PS 1.15x) which could compress further if growth remains elusive, as the market may assign a permanent 'no-growth' multiple. The stock's beta of 0.051 indicates it has been a dramatic underperformer in a rising market, creating sector rotation risk if investors flee defensive laggards for growth. Competitive disruption is a persistent threat, with news highlighting format innovation reshaping the $438B functional food market, directly challenging KHC's legacy packaged goods portfolio.
Worst-Case Scenario: The worst-case scenario involves a failure of the strategic turnaround, leading to further market share erosion, a dividend cut if free cash flow weakens, and a re-rating to a permanent deep-value multiple. This could trigger a breakdown below the key $21.035 technical support (52-week low), potentially revisiting levels implied by the stock's -31.16% max drawdown. From the current price of $21.94, a realistic adverse scenario could see a decline of 15-20%, pushing the stock toward the $17.50-$18.50 range, representing a loss investors must be prepared to withstand.
FAQ
The key risks are, in order of severity: 1) Fundamental Stagnation Risk: Persistent revenue decline challenges the core business model. 2) Dividend Sustainability Risk: While currently supported by strong FCF, any deterioration could threaten the high 6.63% yield, a key attraction. 3) Turnaround Execution Risk: The strategic reversal led by Berkshire may fail to reignite growth. 4) Sentiment & Technical Risk: The stock is in a pronounced downtrend, trading near 52-week lows, and could break support, triggering further selling.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock range-bound between $22 and $25, as it delivers estimated EPS near $2.20 but fails to reignite growth. The Bull Case (25%) targets $27 to the 52-week high of $29.74 on successful turnaround execution. The Bear Case (20%) warns of a drop to $18-$21 if fundamentals worsen. The most likely outcome is the base case of sideways movement, driven by its high yield offsetting a lack of growth catalysts.
KHC is fairly valued to slightly undervalued based on a distressed asset perspective, but potentially overvalued if growth never materializes. The trailing PS ratio of 1.15x is near the bottom of its historical range and represents a discount to many packaged food peers, suggesting undervaluation. However, the forward P/E of 10.27x is reasonable only if the company delivers the estimated $2.20 EPS. The valuation implies the market expects minimal growth and has priced in significant skepticism, creating a deep-value opportunity that could also be a 'value trap'.
KHC is a speculative buy only for a specific type of investor. For income-focused, value-oriented investors with a high risk tolerance and a long time horizon, the 6.63% dividend yield and deeply depressed valuation (PS 1.15x) may be attractive. However, given the persistent revenue decline (-3.38% YoY), analyst downgrades, and severe underperformance (-25.98% over 1 year), it is not a good buy for growth investors or those seeking low-risk stability. The investment thesis hinges entirely on a successful, Berkshire-backed turnaround.
KHC is strictly a long-term investment for patient, income-focused holders. Its ultra-low beta (0.051) and high yield suggest it is unsuitable for short-term trading, as it lacks positive momentum catalysts and has dramatically underperformed the market. The turnaround narrative, if it exists, will take years to unfold. Investors should be prepared to hold for a minimum of 3-5 years to collect the dividend and allow time for strategic initiatives to potentially bear fruit, while weathering potential further volatility.